Swaminathan P. Iyer, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some insights into treatment approaches for T-cell lymphoma, highlighting the challenges with treating this disease. Dr Iyer first comments on the heterogeneity of T-cell lymphoma, and the various subsets that exist, and then goes on to explain common treatment approaches and upcoming clinical trials in this space. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.